1. Home
  2. MOGO vs ENLV Comparison

MOGO vs ENLV Comparison

Compare MOGO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mogo Inc.

MOGO

Mogo Inc.

HOLD

Current Price

$1.30

Market Cap

29.0M

Sector

N/A

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.97

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGO
ENLV
Founded
2003
2005
Country
Canada
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.0M
26.6M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
MOGO
ENLV
Price
$1.30
$0.97
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$4.00
$7.00
AVG Volume (30 Days)
145.9K
11.0M
Earning Date
11-07-2025
11-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$29,215,516.00
N/A
Revenue This Year
$61.97
N/A
Revenue Next Year
$6.28
N/A
P/E Ratio
$5.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.83
52 Week High
$3.83
$2.10

Technical Indicators

Market Signals
Indicator
MOGO
ENLV
Relative Strength Index (RSI) 41.09 46.57
Support Level $1.11 $0.88
Resistance Level $1.26 $1.06
Average True Range (ATR) 0.08 0.12
MACD 0.02 -0.00
Stochastic Oscillator 64.52 14.12

Price Performance

Historical Comparison
MOGO
ENLV

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: